4-methylumbilliferon (4-MU) as a Potential Treatment Against Cerebral ischemia and Reperfusion Injury in Rats; An Experimental Study
Archives of Academic Emergency Medicine,
Vol. 13 No. 1 (2025),
6 Shahrivar 2025
,
Page e8
https://doi.org/10.22037/aaem.v13i1.2456
Abstract
Introduction: Ischemic stroke (IS) is one of the three main fatal disorders and is a major health challenge. 4-methylumbelliferone (4-MU) is one of the coumarin derivatives (7–hydroxy‐4–methylcoumarin) with antioxidant and anti-inflammatory impact. This study was conducted to elucidate the neuroprotective effects and anti-inflammatory impact of 4-MU in a rodent model of IS.
Methods: The IS model was induced by middle cerebral artery occlusion (MCAO) for 1 hour and reperfusion was established for 24 hours. 44 Male Wistar rats were assigned into four groups: (1) Sham, (2) MCAO (3) MCAO + Vehicle, and (4) MCAO + 4-MU (25 mg/kg). Evaluation of neurological deficit was performed using Garcia's score. 2,3,5-triphenoyl-2H-tetrazolium chloride (TTC) staining was employed to measure infarct size. Nissl staining was applied to determine neuronal loss. Moreover, western blotting was utilized to detect the expression of the proteins relevant to the TLR4/NF-κB/NLRP3 axis (p–NF–κB p65, TLR4, NLRP3, IL-1β, IL-10, IL-18, ASC, and Caspase-1).
Results: It was observed that MCAO caused neurological deficit (P<0.0001), infarct (P<0.0001), and neuronal loss (P<0.002); up-regulated NLRP3 (P<0.0001), TLR4 (P<0.0001), p–NF–κB p65 (P<0.0005), IL-1β (P<0.0014), IL-18 (P<0.0001), ASC (P<0.0027), and Caspase-1 (P<0.0052); and reduced IL-10 concentrations (P<0.0024). Administration of 4-MU (25 mg/kg) quickly after reperfusion reduced neurological deficit (P<0.0001), infarct size (P<0.0001), neuronal loss (P<0.0058), and down-regulated NLRP3 (P<0.0257), TLR4 (P<0.0001), p–NF–κB p65 (P<0.0075), IL-1β (P<0.0106), IL-18 (P<0.0005), ASC (P<0.0072), and Caspase-1 (P<0.0315), and increased IL-10 concentrations (P<0.0215).
Conclusion: These results indicate that 4-MU can attenuate injury after MCAO by suppressing the TLR4/NF-κB/NLRP3 axis. Our findings show that 4-MU can be considered a novel therapeutic compound to cure IS.
- Ischemic stroke
- 4-methylumbilliferon
- Inflammation
- TLR4/NF-κB/NLRP3 pathway
- nerve function
How to Cite
References
Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet Neurology. 2016;15(8):869-81.
Ding Q, Liu S, Yao Y, Liu H, Cai T, Han L. Global, regional, and national burden of ischemic stroke, 1990–2019. Neurology. 2022;98(3):e279-e90.
Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology. 2015;45(3):161-76.
Rochmah TN, Rahmawati IT, Dahlui M, Budiarto W, Bilqis N. Economic burden of stroke disease: a systematic review. International journal of environmental research and public health. 2021;18(14):7552.
Chen L, Zhang G, Gu Y, Guo X. Meta-analysis and systematic review of neural stem cells therapy for experimental ischemia stroke in preclinical studies. Scientific Reports. 2016;6(1):32291.
Uivarosan D, Bungau S, Tit DM, Moisa C, Fratila O, Rus M, et al. Financial burden of stroke reflected in a pilot center for the implementation of thrombolysis. Medicina. 2020;56(2):54.
Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. The Lancet. 2007;369(9558):275-82.
Yu WM, Abdul-Rahim AH, Cameron AC, Kõrv J, Sevcik P, Toni D, et al. The incidence and associated factors of early neurological deterioration after thrombolysis: results from SITS registry. Stroke. 2020;51(9):2705-14.
Hernández IH, Villa-González M, Martín G, Soto M, Pérez-Álvarez MJ. Glial cells as therapeutic approaches in brain ischemia-reperfusion injury. Cells. 2021;10(7):1639.
Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. Journal of leukocyte biology. 2010;87(5):779-89.
Burguillos MA, Svensson M, Schulte T, Boza-Serrano A, Garcia-Quintanilla A, Kavanagh E, et al. Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation. Cell reports. 2015;10(9):1626-38.
Xu S, Lu J, Shao A, Zhang JH, Zhang J. Glial cells: role of the immune response in ischemic stroke. Frontiers in immunology. 2020;11:294.
Cao B-Q, Tan F, Zhan J, Lai P-H. Mechanism underlying treatment of ischemic stroke using acupuncture: transmission and regulation. Neural Regeneration Research. 2021;16(5):944.
Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, et al. A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. Journal of Biological Chemistry. 2004;279(32):33281-9.
Lokman NA, Price ZK, Hawkins EK, Macpherson AM, Oehler MK, Ricciardelli C. 4-Methylumbelliferone inhibits cancer stem cell activation and overcomes chemoresistance in ovarian cancer. Cancers. 2019;11(8):1187.
An G, Park S, Lee M, Lim W, Song G. Antiproliferative effect of 4-methylumbelliferone in epithelial ovarian cancer cells is mediated by disruption of intracellular homeostasis and regulation of PI3K/AKT and MAPK signaling. Pharmaceutics. 2020;12(7):640.
Pibuel MA, Poodts D, Sias SA, Byrne A, Hajos SE, Franco PG, et al. 4-Methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells. Scientific Reports. 2023;13(1):9356.
Wang H-N, Xiang Q-A, Lin H-H, Chen J-N, Guo W-J, Guo W-M, et al. Plant-derived molecule 4-methylumbelliferone suppresses FcεRI-mediated mast cell activation and allergic inflammation. Molecules. 2022;27(5):1577.
Chistyakov DV, Nikolskaya AI, Goriainov SV, Astakhova AA, Sergeeva MG. Inhibitor of hyaluronic acid synthesis 4-methylumbelliferone as an anti-inflammatory modulator of lps-mediated astrocyte responses. International Journal of Molecular Sciences. 2020;21(21):8203.
Amani H, Mostafavi E, Alebouyeh MR, Arzaghi H, Akbarzadeh A, Pazoki-Toroudi H, et al. Would colloidal gold nanocarriers present an effective diagnosis or treatment for ischemic stroke? International Journal of Nanomedicine. 2019:8013-31.
Garcia JH, Wagner S, Liu K-F, Hu X-j. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke. 1995;26(4):627-35.
Benedek A, Cernica D, Mester A, Opincariu D, Hodas R, Rodean I, et al. Modern concepts in regenerative therapy for ischemic stroke: from stem cells for promoting angiogenesis to 3D-bioprinted scaffolds customized via carotid shear stress analysis. International Journal of Molecular Sciences. 2019;20(10):2574.
Fann DY-W, Lee S-Y, Manzanero S, Chunduri P, Sobey CG, Arumugam TV. Pathogenesis of acute stroke and the role of inflammasomes. Ageing research reviews. 2013;12(4):941-66.
Galkina SI, Fedorova NV, Ksenofontov AL, Golenkina EA, Serebryakova MV, Stadnichuk VI, et al. Inhibitor of Hyaluronic Acid Synthesis 4-Methylumbelliferone Suppresses the Secretory Processes That Ensure the Invasion of Neutrophils into Tissues and Induce Inflammation. Biomedicines. 2022;10(2):314.
Wang M, Yao M, Liu J, Takagi N, Yang B, Zhang M, et al. Ligusticum chuanxiong exerts neuroprotection by promoting adult neurogenesis and inhibiting inflammation in the hippocampus of ME cerebral ischemia rats. Journal of Ethnopharmacology. 2020;249:112385.
Tang S-C, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences. 2007;104(34):13798-803.
Bao Z, Zhang S, Li X. MiR-5787 attenuates macrophages-mediated inflammation by targeting TLR4/NF-κB in ischemic cerebral infarction. Neuromolecular medicine. 2021;23(3):363-70.
Kopitar-Jerala N. Innate immune response in brain, NF-kappa B signaling and cystatins. Frontiers in molecular neuroscience. 2015;8:73.
Schroder K, Tschopp J. The inflammasomes. cell. 2010;140(6):821-32.
Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature medicine. 2015;21(3):248-55.
Ye Y, Jin T, Zhang X, Zeng Z, Ye B, Wang J, et al. Meisoindigo protects against focal cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia/macrophage polarization via TLR4/NF-κB signaling pathway. Frontiers in cellular neuroscience. 2019;13:553.
Kes VB, Simundic A-M, Nikolac N, Topic E, Demarin V. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clinical biochemistry. 2008;41(16-17):1330-4.
Ge Y, Wang L, Wang C, Chen J, Dai M, Yao S, et al. CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke. Life Sciences. 2022;300:120564.
Li R, Zhou Y, Zhang S, Li J, Zheng Y, Fan X. The natural (poly) phenols as modulators of microglia polarization via TLR4/NF-κB pathway exert anti-inflammatory activity in ischemic stroke. European journal of pharmacology. 2022;914:174660.
Li F, Hao P, Liu G, Wang W, Han R, Jiang Z, et al. Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:559-66.
Irvine SF, Gigout S, Stepankova K, Varea NM, Urdzikova LM, Jendelova P, et al. 4-methylumbelliferone enhances neuroplasticity in the central nervous system: potential oral treatment for SCI. BioRxiv. 2023:2023.01. 23.525137.
Dubisova J, Burianova JS, Svobodova L, Makovicky P, Martinez-Varea N, Cimpean A, et al. Oral treatment of 4-methylumbelliferone reduced perineuronal nets and improved recognition memory in mice. Brain Research Bulletin. 2022;181:144-56.
- Abstract Viewed: 859 times
- pdf Downloaded: 1917 times
Download Statastics
Make a Submission
SJR
COPE
